Fundraising Fox

Albert Cha

Investor

Managing Partner at Frazier Life Sciences Β· Managing Partner at Vivo Capital

Palo Alto

FoundedAclaris Therapeutics

About

Albert Cha is a Managing Partner on Frazier's Life Sciences team, which he co-leads, and co-manages the Frazier Life Sciences Public Fund; he joined the firm in 2021 with over 25 years of experience investing in biopharmaceutical and medical device companies. He was previously a Managing Partner at Vivo Capital and earlier worked at Oracle Corporation in pharmaceutical consulting and at the Palo Alto VA Hospital as a biomedical engineer. He holds B.S. and M.S. degrees in Electrical Engineering from Stanford University and completed the Medical Scientist Training Program at UCLA School of Medicine, earning an M.D. and a Ph.D. in Neuroscience.

Invests in

BiotechMedical Devices

Experience

  1. Frazier Life SciencesManaging Partnercurrent2021 β€” present
  2. Ascendis PharmaChairmancurrent2021 β€” presentCopenhagen, Capital Region of Denmark, Denmark
  3. KalVista Pharmaceuticals, Inc.Board Member2016 β€” 2024Cambridge, Massachusetts, United States
  4. Vivo CapitalManaging Partner2000 β€” 2020
  5. OracleConsultant1992 β€” 1993

Education

  1. Stanford UniversityM.S., Electrical Engineering
  2. Stanford UniversityB.S., Electrical Engineering
  3. UCLAM.D./Ph.D., Neuroscience

Skills & more

Medical Devices19Clinical Trials6Start-ups16Biopharmaceuticals4Corporate Development5MergersBusiness StrategyPrivate Equity1Due Diligence2Entrepreneurship3ValuationCorporate Finance
+8 moreFinancial ModelingManagement ConsultingProduct ManagementProduct DevelopmentM&A experiencePharmaceutical IndustryStrategic PlanningStrategy

From Albert's professional profile.

Same school

Shared employers

Investments

Board seats

Aclaris TherapeuticsAscendis Pharma A/SBiohaven PharmaceuticalsKalVista Pharmaceuticals

Per the firm's website.

Colleagues at Frazier Life Sciences

Network7

Investors connected to Albert in public investor directories β€” a warm-intro map.